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Abstract
The Rap1-GTP interacting adapter protein (RIAM) is an important protein in Rap1-mediated integrin activation. By binding
to both Rap1 GTPase and talin, RIAM recruits talin to the cell membrane, thus facilitating talin-dependent integrin
activation. In this article, we studied the role of the RIAM Ras-association (RA) and pleckstrin-homology (PH) domains in the
interaction with Rap1. We found that the RA domain was sufficient for GTP-dependent interaction with Rap1B, and the
addition of the PH domain did not change the binding affinity. We also detected GTP-independent interaction of Rap1B
with the N-terminus of RIAM. In addition, we found that the PH domain stabilized the RA domain both in vitro and in cells.
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Introduction
Integrins are transmembrane adhesion receptors that are
important in cell adhesion and migration. These heterodimers
contribute to vital events, such as development, haemostasis and
immunity [1]. Integrins are bidirectional signaling receptors; they
mediate signals both from the inside of the cell to the outside and
vice versa. Integrin inside-out signaling can be triggered by several
transmembrane receptors, and the generated signal is propagated
in the cytoplasm to the integrin cytoplasmic domains. The
cytoplasmic interactions then cause changes in integrin affinity
for extracellular ligands, thus activating integrins [2]. The Ras-
family of small GTPases are important signaling elements that
control integrin function [3]. The small GTPases act as molecular
switches by cycling between an active GTP-bound and an inactive
GDP-bound conformation. The cycle is facilitated by guanine
nucleotide exchange factors (GEFs) and GTPase-activating
proteins (GAPs) [4,5]. Whereas Ras GTPases are mainly thought
to play a role in cell proliferation and cell survival, Rap1 has
a pronounced role in integrin-dependent cell adhesion and
spreading [4]. It is shown to regulate the affinity and avidity of
integrins in leukocytes [6–8] and in platelets [9] as well as in
epithelial cells [10].
Canonical Rap1 effectors bind to the conserved switch region of
GTPase with their Ras-associating (RA) domain or similar Ras-
binding domain (RBD) [5]. These domains form a well-defined
ubiquitin-like fold that interacts with the GTPase in order to form
an inter-protein b sheet between the proteins [11]. This
interaction is GTP-sensitive because of the stabilizing role of
GTP in switch regions [5,12]. One of the Rap1 effectors [13],
called the Rap1-GTP interacting adapter molecule (RIAM) has
been shown to link Rap1 signaling to b1, b2 and b3 integrin
activation [14–17]. The key event in intergrin activation is the
binding of talin to the cytoplasmic domain of integrins [18]. This
event is facilitated by RIAM, which, by binding both Rap1 and
talin, recruits the integrin activation complex to the plasma
membrane. At the plasma membrane, talin can then interact with
and activate integrins [15–17]. RIAM belongs to the Mig-10/
RIAM/Lamellipodin (MRL) family of adaptor proteins [14]. The
MRL members share a similar domain composition, with
consecutive Ras-association (RA) and pleckstrin-homology (PH)
domains flanked by proline-rich regions. This central RA-PH
domain pair is preceded by a conserved patch of 27 residues that is
predicted to form a coiled-coil structure (Figure 1A). The related
Grb7 family of adaptor proteins shares several structural
characteristics with MRL proteins, including the RA-PH domain
pair [14].
In addition to talin and Rap1, RIAM has been shown to bind to
the profilin and Ena/VASP family of proteins with its proline-rich
regions. Therefore, it is shown to be an important mediator in
actin cytoskeleton dynamics and is involved in lamellipodia
formation [14,19]. RIAM has also been shown to interact with
the ADAP/SKAP-55 protein module, which has a recruiting role
regarding the RIAM/Rap1 complex [20]. The interaction
involves the central region of RIAM, including the RA-PH
domain pair. Both RA and PH domains of RIAM have also been
shown to be important in the interaction with Rap1. In yeast two-
hybrid assays, the interaction required an intact RA-PH domain
pair [14], whereas other experiments have questioned the
requirement of the PH domain for the interaction [17]. Therefore,
the exact role of the PH domain in Rap1-RIAM interaction has
remained partially elusive.
To study the role of the RA and PH domains in the interaction
of RIAM with Rap1, we used pull-down assays in combination
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e31955with thermal stability and proteolysis assays. We show that the RA
domain of RIAM was sufficient for interaction with Rap1B in vitro.
Furthermore, the RA domain required a consecutive PH domain
in order to remain stable in vitro and in cells. Therefore, our results
propose a novel stabilizing role of the PH domain in MRL
proteins.
Results
RIAM Binds to Rap1B with its N-terminus and the RA
Domain
Rap1-GTP interacting adapter molecule (RIAM), as its name
indicates, interacts with small GTPase Rap1 [14]. Previous
studies have indicated that the RA domain is required for the
interaction [14,17]. To find out whether the RA domain is
sufficient for Rap1 binding, pull-down assays of purified active
Rap1B-Gpp(NH)p with different GST-RIAM constructs were
conducted. The two Rap1 isoforms (Rap1A and Rap1B) are
95% identical in amino acid sequence. The difference is mainly
restricted to the C-terminus of both isoforms that is excluded
from the Rap1B construct used in this article (amino acids 1–
167). Therefore the following results should be applicable to
both Rap1 isoforms. The RIAM constructs consisted of an N-
terminal fragment (RIAM1-176), the RA domain (RIAM1-261,
RIAM150-261) or both RA and PH domains (RIAM1-502,
RIAM150-502) (Figure 1A). All the RIAM constructs interacted
with Rap1B (Figure 1B).
Figure 1. The binding of active Rap1B to RIAM constructs. (A) Schematic diagram of the RIAM constructs. RIAM constructs of varying lengths
were expressed and tested; the residue range of each construct is shown on the left. Full-length RIAM is included in the figure, with domain
boundaries marked according to UniProtKB sequence annotation of the entry AB1IP_HUMAN and [14]. Abbreviations: C – coiled-coil, P – proline-rich
region, RA – Ras-association domain, PH – pleckstrin-homology domain. (B) Pull-down of purified Rap1B-Gpp(NH)p with GST-RIAM constructs and
controls. The GST-RIAM constructs indicated in panel A were bound to glutathione Sepharose, and soluble 1 mM purified Rap1B was allowed to bind.
The Western blot membranes were labeled with anti-Rap1B. The 50 ng Rap1B input is included as a reference. The amount and size of GST-RIAM
constructs used in the assay (asterisks) are indicated in a Coomassie Brilliant Blue-stained SDS-PAGE gel. The molecular weight marker (LMW, GE
Healthcare) with corresponding molecular weights are indicated on the right.
doi:10.1371/journal.pone.0031955.g001
RIAM RA Domain Binding and Stability
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effector Interactions. This Interaction is Dependent on
Rap1B Activity State
In order to further characterize the interactions, the assays we
repeated with various concentrations of either Rap1B-Gpp(NH)p or
Rap1B-GDP. The binding of Rap1B-GDP to the RIAM RA
domain construct (RIAM150-261) was remarkably weaker than
that of Rap1B-GTP (Figure 2B and C). This shows that the
binding of Rap1B to the RIAM RA domain is GTP dependent.
On the other hand, the binding of Rap1B to the N-terminal
fragment of RIAM (RIAM1-176) was not GTP dependent
(Figure 2D). The fragment containing the RA and PH domains
(RIAM150-502), bound Rap1B-Gpp(NH)p similarly as the RA-
domain construct. The dissociation constants (Kd) were (0.33 6
0.09) mM for RIAM150-261 and (0.7 6 0.4) mM for RIAM150-
502 (Figure 2A and B). The residuals fitted well to the curve
determined by nonlinear regression, and the values for the
goodness of the fit of both RIAM150-261 (R
2: 0.96) and
RIAM150-502 (R
2: 0.92) were close to 1.0. The similar affinities
of these two constructs imply that the PH domain does not have
a clear impact on the binding of RIAM to Rap1B in vitro.
The dissociation constants of RIAM1-176 with Rap1B-
Gpp(NH)p or Rap1B-GDP, or RIAM150-261 with Rap1B-GDP
could not be determined as the saturation could not be achieved.
Taken together, our binding measurements suggest that the main
Rap1 GTP-dependent binding site resides on the RA domain of
RIAM. This is consistent with a GTP-dependent interaction of
Rap1 switch regions with the RA domain [21]. In addition to this
the N-terminus of RIAM also participates in the interaction,
independent on the GTP binding of Rap1.
The RIAM RA Domain is Unstructured, but Stabilized by
the PH Domain Both in vitro and in vivo
Although RIAM-Rap1B interaction does not require a PH
domain in vitro, the RIAM PH domain could have an impact on
RA domain stability. The crystal structure of Grb10, a relative of
the MRL proteins, reveals a compact RA-PH structure [22]. As
the RA and PH domains are also in close contact with each other
in MRL proteins, we next tested whether the PH domain would
affect the stability of the RA domain [14,22]. To study this, we first
employed limited proteolysis. RIAM constructs were digested with
chymotrypsin and run in SDS-PAGE after different incubation
times (Figure 3A-D). All the RIAM fragments (Figure 3A-C) were
considerably less stable than glutathione S-transferase (GST)
(Figure 3D) in this analysis. No partial digestion products were
observed from the RIAM150-261 construct (Figure 3A). The
RIAM1-261 construct gave a partially stable subfragment
migrating at Mw ,22 kDa (Figure 3B) and the RIAM150-502
gave a subfragment migrating at Mw ,35 kDa (Figure 3C), based
on the SDS-PAGE analysis. Further peptide fingerprinting (Figure
S1) suggested that the subfragment of RIAM1-261 was truncated
from the N-terminus and thus contained the RA domain. From
the subfragments of RIAM150-502, peptides ranging over amino
acids 182–459 could be identified, suggesting the presence of both
RA and PH domains in this partially stable subfragment. Thus,
based on limited proteolysis, the predicted RA domain and the
RA-PH domain pair could be identified as folded units.
To further investigate the stability of the RIAM constructs, the
ThermoFluor method [23] was used. ThermoFluor distinguishes
the folded and unfolded nature of a protein by using a fluorophore
that binds to the hydrophobic parts of protein. When the protein is
thermally denatured, more of the hydrophobic interior will be
exposed and the fluorophore emission increases. The Thermo-
Fluor profiles of RIAM1-261 and RIAM150-261 were featureless
(Figure 3E), suggesting that the constructs have unfolded
characteristics. This result differs from the limited proteolysis
assay, but it is possible that the small amount of partially stable RA
domain seen in limited proteolysis may not be detectable in the
ThermoFluor assay or that this domain contains hydrophopic
surface accessible for the fluorophore. In contrast to this,
RIAM150-445 gave a characteristic denaturation curve with
a melting temperature (Tm) of 52.5uC, and the RIAM150-502
constructs had a Tm of 50.0uC (Figure 3E). A possible explanation
for the observed difference between the RA domain and the RA-
PH domain fragment is that the PH domain of RIAM is required
for stability of the RA domain.
Also, the possibility that Rap1B binding could stabilize the
RIAM RA domain was tested. The proteins RIAM150-261 and
Rap1B-Gpp(NH)p were analyzed with ThermoFluor individually
or together in a 1:1 molar ratio. The concentration of each protein
was 10 mM, which was far above the concentration required for
the saturation of the interaction, as determined above. The profile
of RIAM150-261 was not affected when Rap1B-Gpp(NH)p (Tm
46uC) was included (Figure 3F). The resulting fluorescence was the
sum of the fluorescence values of the individual proteins, but no
clear change in the RIAM150-261 fluorescence input was seen.
Therefore, Rap1B binding did not affect the stability of the RA
domain in the ThermoFluor assay.
To test whether the PH domain is also required for the stability
of the RA domain in vivo, CHO cells were transfected with myc-
tagged RIAM constructs having full-length RIAM (RIAM FL), the
RA domain only (RIAM150-261) or the RA-PH domain pair
(RIAM150-445). The transfected cells were treated with cyclo-
heximide to inhibit protein synthesis, and the samples were
collected after various incubation times to observe protein
turnover. The RA domain-only construct was almost totally
degraded after 2 hours, whereas the full-length RIAM and the
RA-PH construct were partially stable even after 6 hours
(Figure 3G and H). In addition, the RA-PH construct appeared
even more stable than the full-length RIAM construct, which
underlines the stable characteristics of the domain pair. This result
further confirms that RIAM requires both the RA and PH
domains in order to form a stable entity in vivo.
Discussion
In the present study, we characterized the direct binding of
small GTPase Rap1B to its effector RIAM and the effect of the PH
domain for RIAM stability. With a biochemical interaction assay,
we showed that RIAM interacts with Rap1B primarily via its RA
domain in vitro. The interaction between RIAM RA domain and
Rap1B had a similar Kd as other Ras-related proteins had with
their effectors that range between 20 nM and 2 mM [24]. This
interaction was GTP-dependent, because Rap1B-GDP showed
only background binding. This implies that the interaction forms
between the Rap1B switch regions and RIAM RA domain, as with
other Rap1B effector interactions [5,11]. The GTP stabilizes the
switch regions, thus enabling effector binding; GDP relaxes these
effector binding regions, thus abrogating binding [5,12]. In
addition to this, we also showed that the N-terminus of RIAM
participates in Rap1 binding in a GTP independent manner.
Our results are consistent with Lee and others, who showed
that RIAM1-301, lacking the PH domain, was sufficient for
interaction with Rap1 for integrin activation [17]. The N-
terminal interaction observed here also fits with previous results
showing that the N-terminal part of RIAM enhances the overall
interaction with Rap1 [14], but is not sufficient for activation of
RIAM RA Domain Binding and Stability
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both the RA and PH domains of RIAM were required in order
to interact with active Rap1 [14]. This discrepancy may be
explained by our finding that the PH domain is required for
stabilization of RIAM RA domain both in vitro and in cell
culture. It is therefore possible that the activity of the partially
unstable RA domain may be detected in some experimental
conditions but not in others.
PH domains usually bind to phosphoinositides, and they have
been shown to be important for the membrane localization of
MRL proteins and the closely-related Grb7 family. Lamellipodin,
a homologous MRL protein, cannot bind to Rap1 with its RA
domain, but its PH domain binds to PtdIns(3,4)P2. The PH
domain localizes lamellipodin to the plasma membrane [25].
When Grb14 was mutated in order to abrogate the phosphoinosi-
tide binding of its PH domain [14], it lost its membrane
Figure 2. Quantitative binding assays of Rap1B to RIAM fragments. Binding assays indicate specific GTP-dependent interaction between
Rap1B and GST-RIAM-RAconstructs. (A and C) RIAM150-261 binds to active Rap1B-Gpp(NH)p in a specific manner (Kd 0.3360.09 mM), whereas the
binding is lost in Rap1B-GDP (Kd not determined). (B) RIAM150-502 binds Rap1B-Gpp(NH)p with an affinity (Kd 0.760.4 mM) similar to that of
RIAM150-261. (D) RIAM 1-176 binds identically to Rap1B-Gpp(NH)p (GTP) and Rap1B-GDP. In all panels the binding of GST-RIAM binding to purified
Rap1B in 0.05, 0.1, 0.3, 0.5, 0.7 and 1.0 mM concentrations is shown as well as the unspecific binding of GST control. The 10 ng Rap1B load is shown
for comparison. The binding was quantified by labeling membranes with anti-Rap1 after Western blotting, and it is expressed as Rap1B binding. The
graph shows total binding (black curve) and the unspecific background binding (grey line). The dissociation constant was calculated as the ratio of
specific to unspecific binding, normalized to maximal Rap1B binding in each experiment (mean 6 S.E. (error bars); n $ 4, exept for D.
doi:10.1371/journal.pone.0031955.g002
RIAM RA Domain Binding and Stability
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domain pair. (A-D) The limited proteolysis analysis of RIAM150-502 (A), RIAM1-261 (B), RIAM150-261 (C) and GST (D). Fragments that appeared
upon a-chymotrypsin treatment are marked with arrows. The incubation times are included in the figure. (E) Temperature denaturation profiles of
RIAM1-261 (blue), RIAM150-261 (red), RIAM 150-445 (yellow) and RIAM150-502 (green). (F) The profiles of Rap1B-Gpp(NH)p (yellow) and RIAM150-261
(red) in individual measurements and measured together (green). All measurements were repeated 5 times and the mean graph is shown. The
fluorescence values are normalized in E and plotted as arbitrary units in F.( G) In vivo proteolysis assay of RIAM constructs in CHO cells. Tranfected
myc-RIAM constructs after various cycloheximide treatment times (0 h, 2 h, 6 h) are labeled with anti-myc. In order to check the comparable sample
amount, the samples were also labeled for a-tubulin. (H) The graph shows qualitatively the same changes to the myc-RIAM amount after
cycloheximide treatment (mean 6 SEM (error bars); n = 2).
doi:10.1371/journal.pone.0031955.g003
RIAM RA Domain Binding and Stability
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and failed to mediate normal insulin signaling [22]. This infers that
the membrane association via the PH domain can be important
for the interaction with small GTPases. The PH membrane
association would position the RA-PH unit on the cell membrane
in such a way that the RA domain could optimally bind to small
GTPases [22].
In contrast to lamellipodin and Grb7 proteins, no phosphoino-
sitides have been characterized as binding to RIAM so far,
although close homology with lamellipodin suggests that RIAM
might have similar specificity [25]. On the other hand, the RIAM
PH domain has been implicated in adaptor protein interaction. In
T-cells, the RIAM PH domain is required for ADAP/SKAP-55
complex interaction [20]. The RA-PH tandem domain pair is not
sufficient for membrane targeting itself. Instead, interaction with
SKAP-55 is required [20]. RIAM binding to SKAP-55 does not
compete with Rap1, and this binding requires both the RA and
(especially) PH domains of RIAM. Abrogation of RIAM/SKAP-
55 interaction leads to impaired cell adhesion after TCR
activation [20].
The MRL proteins and Grb7 proteins have a characteristically
conserved RA-PH domain pair [14]. The crystal structure of
Grb10 shows a pair of canonically folded RA and PH domains
that have an extensive interface (1326 A ˚ 2) between the domains
[22]. The interface has a hydrophobic cluster that is also
conserved in the MRL protein family members; the corresponding
residues are usually hydrophilic in the single RA domains of other
proteins [22]. This provides a possible structural explanation for
the requirement of the PH domain for RA domain stability
reported here. Furthermore, in the Grb10 RA-PH structure, the
G-protein binding surface of the RA domain is located opposite of
the PH domain interaction surface [22]. This is consistent with our
finding that the RIAM RA domain alone is sufficient for Rap1
interaction.
Materials and Methods
Antibodies
The c-Myc antibody (9E10) was from Santa Cruz Biotechnol-
ogy (Santa Cruz, CA). The polyclonal Rap1 antibody, polyclonal
anti-mouse HRP-conjugate and polyclonal anti-rabbit HRP-
conjugate were from Millipore (Temecula, CA). The a-tubulin
antibody (DM1A) was from Cedarlane (Ontario, Canada).
Cloning and Constructs
The plasmid containing full-length RIAM [17] was a kind gift
from Dr. Mark Ginsberg. RIAM fragments were amplified by
standard PCR and introduced to a modified pGEX-4T3 vector
(GE Healthcare) with a tobacco etch virus protease cleavage site.
For assays in cells, full-length RIAM was replaced with truncated
inserts with ClaI and XbaI restriction sites. Construct pGEX-
4T3/Rap1B was generously provided by Dr. Alfred Wittinghofer.
Protein Expression and Purification
For protein expression, BL21 GOLD cells were transformed,
and positive clones were selected with 100 mg/ml ampicillin.
Protein expression was induced with 0.4 mM IPTG at OD 0.6,
and the expression was conducted at 23uC for 18 h. After
expression, cells were collected by centrifugation and re-suspended
in PBS. Cells were disrupted by French Press (2000 psi) and the
lysate was centrifuged at 20,000 6g for 30 min. The soluble part
of the lysate was coupled to Glutathione Sepharose 4B (GE
Healthcare Life Sciences) by incubating for 2 h at +4uC and
washed with PBS. The bound GST-fusion protein was eluted with
reduced glutathione (Sigma). The protein was further purified with
size exclusion chromatography using a HiLoad 16/600 Superdex
75 column (GE Healthcare Life Sciences) in 100 mM NaCl,
1 mM DTT, 20 mM Tris pH 8.0. The selected fractions were
concentrated and flash-frozen for later use.
Rap1B Nucleotide Exchange Reaction
Before size exclusion chromatography, Rap1B was activated
with 100x the molar amount of GDP or non-hydrolysable GTP-
analog Gpp(NH)p (Sigma), as in [26]. The reaction was conducted
in 40 mM Tris, 12 mM EDTA, 3 mM DTT pH 7.4 for 1 h at
23uC, and it was stopped by adding 25 mM MgCl2. Rap1B was
then purified with size exclusion chromatography as above, but
3 mM MgCl2 was included in the buffer.
Pull-down Experiments and Affinity Assays
The pull-down experiments were performed in Buffer A
(50 mM Tris pH 7.5, 200 mM NaCl, 2 mM MgCl2, 10%
glycerol, 1 mM DTT, 1% Triton X-100). The desired amount
of purified Rap1B was incubated for 1 h in 10 ml of GST-RIAM-
coupled Glutathione Sepharose 4B (GE Healthcare Life Sciences).
The samples were then washed 5 times with Buffer A (centrifuga-
tions at 1700 6 g for 2 min RT) and eluted with SDS
electrophoresis sample buffer.
Immunoblotting and Densitometric Analysis
The samples from the pull-down assays were run on an SDS-
PAGE and the fractionated samples were analyzed by Western
blotting and detected with Millipore (Temecula, CA) HRP-
conjugated secondary antibodies and enhanced chemilumines-
cence (ECL) Western blotting substrate (product number 32106;
Pierce, Rockford, IL). The intensities of the protein bands were
analyzed with ImageJ (http://rsbweb.nih.gov/ij/). The affinity
constants were estimated as in [27] by using the GraphPad Prism
5.03 program (GraphPad Software, Inc, La Jolla, CA).
Limited Proteolysis
RIAM constructs were analyzed by limited proteolysis [28] with
a-chymotrypsin (Sigma), as in [29]. Protease was added to the
protein in a 1:1000 ratio, and proteolysis reactions were performed
in 20 mM Tris, pH 8.0, 100 mM NaCl, 1 mM DTT at room
temperature. Samples were taken after various incubation time
intervals and analyzed in 12% SDS-polyacrylamide gel electro-
phoresis (PAGE) with Coomassie protein staining. The migration
of the proteolytic fragments was analyzed with the Quantity One
4.6.3 (Bio-Rad) program.
Peptide Mass Fingerprinting
After SDS-PAGE fractionation, Coomassie stained gel bands
were excised from the gel and digested with trypsin. The tryptic
peptides were analyzed by Bruker UltrafleXtreme MALDI-ToF
mass spectrometer (Bruker Corporation, Billerica, MA) and
correlated with the protein sequence to estimate the protein area
subjected to chymotrypsin digestion as described elsewhere [30].
Thermofluor Experiments
The thermal stability of the proteins was determined using
a C1000 Thermal cycler and CFx96 Real-Time system (Bio-Rad).
Thermal denaturation over a 20uC–9 5 uC temperature gradient
was monitored in 0.5uC/30 s increments. Samples consisted of
5 mMo r1 0mM protein and 5x SYPRO Orange fluorescent dye
(Invitrogen) in 25 ml final volume of 100 mM NaCl, 1 mM DTT,
20 mM Tris pH 8.0. For measurements with Rap1B-Gpp(NH)p,
RIAM RA Domain Binding and Stability
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with GraphPad Prism 5.03.
Cell Culture and Proteolysis Assay
Chinese hamster ovary (CHO) cells were cultured according to
normal practice in a medium consisting of 10% fetal bovine
serum, 1% non-essential amino acids (GIBCO) and desired
antibiotics. Cells were transfected with Lipofectamine 2000
(Invitrogen), according to the manufacturer’s instructions. 24 h
after transfection, 500 mg/ml cycloheximide (Sigma) was added to
the culture medium and incubated for 2 h or 6 h. 0 h samples
were not treated with Cycloheximide. After incubation periods,
the cells were harvested, lysed into Buffer A and analyzed by
Western blotting. Figures from the experiments were made with
ImageJ and GraphPad Prism 5.03.
Supporting Information
Figure S1 Analysis of the tryptic peptides and correla-
tion with the protein sequence. The results of mass
spectrometric analysis of tryptic peptides from the fragments
generated by limited proteolysis (arrows in Figure 3B and C) are
shown for the RIAM1-261, spanning from the N-terminus to the
end of the RA domain, and RIAM150-502, including the RA-PH
domain pair. In each panel, the upper box shows the identified
peptides under the input sequence. The lower print lists the
observed and calculated peptide masses and sequences. Note that
the sequence numbering in the upper box starts from the
beginning of the construct. Both constructs have a vector-derived
sequence GAMG at the N-terminus.
(PDF)
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